Deliver Your News to the World

Frontage Laboratories Receives AAALAC Certification


(Exton, PA; February 25, 2010) – Frontage Laboratories, Inc. (“Frontage”), a leading provider of preclinical DMPK, CMC drug development & CTM manufacturing, bioanalytical, clinical and consulting services, has achieved AAALAC International accreditation on February 9, 2011.

The Association for Assessment and Accreditation of Laboratory Animal Care evaluates organizations that utilize animals in research, teaching or testing to ensure and promote animal well being in science. Frontage conducted an extensive internal review, and was then assessed on-site by the AAALAC evaluators regarding all aspects of animal care and use.

Frontage’s animal facility is overseen by Vice President of DMPK services Dr. Abdul Mutlib, who has over 20 years of drug metabolism research experience. Having contributed to over 60 publications and patents, Dr. Mutlib is a thought leader in studies of Metabolites in Safety Toxicology (MIST), metabolite characterization, reactive metabolites, and metabolism-mediated toxicities.

Jim Burleigh, Lab Manager, is the primary head for the animal facility. Mr. Burleigh has over 25 years of experience in conducting ADME studies in laboratory animals. Jim has held various positions in this field with Parke-Davis, Wyeth, BASi, and Pfizer.

About Frontage
Frontage Laboratories, Inc. is a dynamic contract research, development and manufacturing organization, offering a full range of pharmaceutical R&D services. As a rapidly expanding contract research organization in the US with a ten-year successful history of its high quality GXP services, Frontage has established an international standard in pharmaceutical product research, quality and management systems.


 animal testing
 drug development
 pharmaceutical research

This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.

News Release Distribution and Press Release Distribution Services Provided by WebWire.